2007 Article Archive CD from the International Journal of Pharmaceutical Compounding

Sign On

Volume 11, 2007 CD
Six back issues from 2007 on one convenient CD.

Permanent storage and easy retrieval of IJPC articles and formulations.

Print journal articles in color from the PDF file for your marketing needs.
Eliminate long searches through past issues for formulations, compatibility studies, standard operating procedures, marketing ideas, and literature reviews.

Only $95 per CD

This CD contains the following articles listed by volume, issue and page number:


Issues Included
Volume/Issue	Date	Title
Vol. 11 No. 1	January/February 2007	Pediatric Patients
Vol. 11 No. 2	March/April 2007	Diabetes
Vol. 11 No. 3	May/June 2007	Pain Management
Vol. 11 No. 4	July/August 2007	Hormone Replacement Therapy
Vol. 11 No. 5	September/October 2007	Veterinary Compounding
Vol. 11 No. 6	November/December 2007	High-Technology Compounding

Volume 11, 2007 CD ARTICLES

Title (Click for Details)	Vol/Issue	Page

Volume 11, 2007 CD ARTICLES
PreScription: IJPC: The Next 10 Years	Vol. 11 No. 1	2
Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development—Pediatric Formulations Initiative, Part 1	Vol. 11 No. 1	5
Principles of Pediatric Palliative Care and Pain Control	Vol. 11 No. 1	10
Pediatric Oral Formulations: A Continual Challenge	Vol. 11 No. 1	17
Sevelamer Suspension in Children with End-Stage Renal Disease	Vol. 11 No. 1	20
Case Report: Cocktail Dosing in a Premature Infant with a History of Cholestasis	Vol. 11 No. 1	26
Case Report: Treatment of Labial Adhesions in a Child	Vol. 11 No. 1	27
Compounding In Crisis:The Aftermath of Hurricane Katrina	Vol. 11 No. 1	28
Information Resources and Software for the Hospital Compounding Pharmacist	Vol. 11 No. 1	36
Psychotropic Medications in the Treatment of Feline Urine Spraying	Vol. 11 No. 1	44
Basics of Compounding for Hazardous Drugs, Part 3: Safe Handling and Personal Protection	Vol. 11 No. 1	50
Quality Control Analytical Methods: The Quality of Sterility Testing	Vol. 11 No. 1	52
Collaborative Drug Therapy Management and its Application to Pharmaceutical Compounding	Vol. 11 No. 1	56
Pharmacogenomics: The End of Trial-and-Error Medicine?	Vol. 11 No. 1	59
Standard Operating Procedure: Refrigerator—Installation,Maintenance, Cleaning, and Power Interruptions	Vol. 11 No. 1	66
Calculations	Vol. 11 No. 1	68
Caffeine Citrate 10-mg/mL Oral Liquid	Vol. 11 No. 1	69
Carbidopa 1.25-mg/mL Oral Liquid	Vol. 11 No. 1	70
Clonidine Hydrochloride 0.1-mg/mL Oral Liquid	Vol. 11 No. 1	71
Dexamethasone 1-mg/mL Oral Liquid	Vol. 11 No. 1	72
Fluoxetine Hydrochloride 1-mg/mL Oral Liquid	Vol. 11 No. 1	73
Lansoprazole 3-mg/mL Oral Liquid	Vol. 11 No. 1	74
Methyldopa 25-mg/mL Oral Liquid	Vol. 11 No. 1	75
Metolazone 1-mg/mL Oral Liquid	Vol. 11 No. 1	76
Prednisone 10-mg/mL Oral Liquid	Vol. 11 No. 1	77
Prednisolone Sodium Phosphate 10-mg/mL Oral Liquid	Vol. 11 No. 1	78
Chemical Stability of Desonide in Ear Drops	Vol. 11 No. 1	79
Physical and Chemical Stability of Palonosetron with Metoclopramide and Promethazine During Simulated Y-Site Administration	Vol. 11 No. 1	82
PostScription: IJPC—More Than a Journal	Vol. 11 No. 1	88
PreScription: Putting the Science Back into Pharmacy	Vol. 11 No. 2	92
Insulins: Historical and Current Perspectives	Vol. 11 No. 2	95
Compounding for the Complications of Diabetes: Interviews with Compounding Pharmacists George B. Muller, RPh, and Jerrod Roberts, DPh	Vol. 11 No. 2	106
Certified Diabetes Educator: A Credential for Compounding Pharmacists	Vol. 11 No. 2	112
Challenges of Compounding for Patients on the Ketogenic Diet	Vol. 11 No. 2	116
Compounded Treatments for Erectile Dysfunction: A Common Complication of Diabetes	Vol. 11 No. 2	122
Including Pets in Diabetic Care	Vol. 11 No. 2	126
Case Report: Shingles Triple Cream in the Treatment of Herpes Zoster	Vol. 11 No. 2	131
Innovative Uses of Compounded Tranilast: An Interview with Compounding Pharmacist Larry J. Frieders, RPh	Vol. 11 No. 2	132
Records and Record-Keeping for the Hospital Compounding Pharmacist	Vol. 11 No. 2	138
Quality Control Analytical Methods: Considerations in Compounding Peroral Solid Dosage Forms	Vol. 11 No. 2	145
Basics of Compounding for Hazardous Drugs, Part 4: Developing the Hazardous Drugs List and Containment Workstations	Vol. 11 No. 2	149
Calculations	Vol. 11 No. 2	152
Standard Operating Procedure: Discarding of Broken Glass	Vol. 11 No. 2	153
Aspirin 80-mg/5-mL Oral Liquid, Anhydrous	Vol. 11 No. 2	154
Busulfan 2-mg/mL Oral Liquid	Vol. 11 No. 2	155
Cefuroxime Axetil 10-mg/mL Oral Liquid	Vol. 11 No. 2	156
Metformin Hydrochloride 100-mg/mL Oral Liquid	Vol. 11 No. 2	157
Ondansetron Hydrochloride 0.8mg/mL Oral Liquid	Vol. 11 No. 2	158
Oral Liquid Vehicle, Anhydrous	Vol. 11 No. 2	159
Phenoxybenzamine Hydrochloride 2-mg/mL Oral Liquid	Vol. 11 No. 2	160
Ranitidine Hydrochloride 15-mg/mL Oral Liquid	Vol. 11 No. 2	161
Tegaserod Meleate 0.1-mg/mL Oral Liquid	Vol. 11 No. 2	162
Triprolidine Hydrochloride 0.25-mg/mL Syrup	Vol. 11 No. 2	163
Stability of Oseltamivir in Various Extemporaneous Liquid Preparations	Vol. 11 No. 2	164
PostScription: Responsibility: A Critical Aspect of Compounding Pharmacy	Vol. 11 No. 2	178
PreScription: State or Federal Control of Pharmacy Practice	Vol. 11 No. 3	178
Transdermal Gel in the Treatment of Postoperative Pain	Vol. 11 No. 3	181
Oral Methadone for Management of Regional Sympathetic Dystrophy Syndrome: A Case Revisited	Vol. 11 No. 3	187
The Rectal Rocket: A Two-Day Treatment for Hemorrhoids	Vol. 11 No. 3	194
Case Report: Ketoprofen/Riboflavin/Caffeine Capsules and Progesterone Therapy for Recurrent Migraine Pain	Vol. 11 No. 3	200
Levorphanol for the Treatment of Severe Chronic Pain	Vol. 11 No. 3	202
Levorphanol for Excruciating Pain from Oral Cancer: A Case Report	Vol. 11 No. 3	212
Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development--Pediatric Formulations Initiative, Part 2	Vol. 11 No. 3	220
Quality Control: Standard Operating Procedures--An Essential Tool for Developing Quality Preparations	Vol. 11 No. 3	226
Basics of Compounding for the Implementation of United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 1	Vol. 11 No. 3	230
Calculations - Compounding for Pain Management	Vol. 11 No. 3	238
Standard Operating Procedure: Basic Compounding Documentation--the Master Formula Form	Vol. 11 No. 3	240
Benazepril 2-mg/mL Oral Liquid	Vol. 11 No. 3	242
Cholecalciferol 40,000-IU/mL Oral Liquid	Vol. 11 No. 3	243
Folic Acid 1-mg/mL Oral Liquid	Vol. 11 No. 3	244
Glycopyrrolate 0.5-mg/mL Oral Liquid	Vol. 11 No. 3	245
Isoproterenol Compound Elixir	Vol. 11 No. 3	246
Levothyroxine Sodium 40-micro-g/mL Oral Liquid	Vol. 11 No. 3	247
Losartan Potassium 2.5-mg/mL Oral Liquid	Vol. 11 No. 3	248
Methylphenidate 1-mg/mL Oral Liquid	Vol. 11 No. 3	249
Thiamine Hydrochloride 100-mg/mL Oral Liquid	Vol. 11 No. 3	250
Trovafloxacin Mesylate 10-mg/mL Oral Liquid	Vol. 11 No. 3	251
Rheologic Profile, Specific Gravity, Surface Tension, and pH of Fifteen Over-the-Counter Preparations	Vol. 11 No. 3	252
Chemical Stability of Hydrocortisone in an Oral Liquid Dosage Form without Suspending Agents	Vol. 11 No. 3	259
PostScription: Lobbying: How It Affects Compounding	Vol. 11 No. 3	262
PreScription: Bias, NAMS, and HRT	Vol. 11 No. 4	266
Correcting Misconceptions about Compounding Bioidentical Hormones: A Review of the Literature	Vol. 11 No. 4	269
The History of Progesterone	Vol. 11 No. 4	274
The Politics of Hormone Replacement Therapy	Vol. 11 No. 4	278
Premarin: The Intriguing History of a Controversial Drug	Vol. 11 No. 4	282
Common Acronyms Used by Health Professionals Who Prescribe or Prepare Hormone Replacement	Vol. 11 No. 4	288
The Lived Experience of Perimenopausal and Menopausal Women Undergoing Treatment with Bioidentical Hormones	Vol. 11 No. 4	292
Obtaining Accreditation by the Pharmacy Compounding Accreditation Board, Part 1: An Overview	Vol. 11 No. 4	297
Book Review: The Rexall Story: A History of Genius and Neglect	Vol. 11 No. 4	300
Update on the Proposed Revision Process for United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations	Vol. 11 No. 4	302
Quality-control Analytical Methods: Logbooks and Documentation Forms	Vol. 11 No. 4	306
Basics of Compounding: The Responsibilities of Compounding Personnel in Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 2	Vol. 11 No. 4	314
Calculations	Vol. 11 No. 4	324
Standard Operating Procedure: U.S. Food and Drug Administration Inspection--Releasing a Sample to the U.S. Food and Drug Administration	Vol. 11 No. 4	326
Fentanyl 50-mg/mL in 0.9% Sodium Chloride Solution	Vol. 11 No. 4	328
Ketoconazole 25-mg Liquid Suppository	Vol. 11 No. 4	329
Mebeverine Hydrochloride 20% gel	Vol. 11 No. 4	330
Moxifloxacin in Dianeal 1.36% Peritoneal Dialysis Solution	Vol. 11 No. 4	331
Oseltamivir 12-mg/mL Oral Suspension	Vol. 11 No. 4	332
Phenytoin Sodium 20-mg/mL Topical Suspension	Vol. 11 No. 4	333
Ribavirin 40-mg/mL Suspension	Vol. 11 No. 4	334
Sufentanil 50-mg/mL in 0.9% Sodium Chloride Solution	Vol. 11 No. 4	335
Temozolomide 10-mg/mL Oral Liquid	Vol. 11 No. 4	336
Vehicle N Formulas	Vol. 11 No. 4	337
Statistical Analysis of Barrier Isolator/Glovebox Glove Failure	Vol. 11 No. 4	338
Chemical Stability of Cyproheptadine Hydrochloride in an Oral Liquid Dosage Form	Vol. 11 No. 4	347
PostScription: Thousands of Unapproved New Drugs are on the U.S. Market, Part 1	Vol. 11 No. 4	350
PreScription: Pharmacy Education: Is It Contemporary?	Vol. 11 No. 5	354
United States Pharmacopeia Convention Standards and Clinical Information for Compounded Medications Used in Veterinary Medicine	Vol. 11 No. 5	357
Rabbit Medicine	Vol. 11 No. 5	364
The Whales: A Pharmacist's Story	Vol. 11 No. 5	376
Equine Cushing's Disease: A Clinical Update	Vol. 11 No. 5	384
Submitting Compelling Case Reports for Drug Therapy in Veterinary Patients	Vol. 11 No. 5	390
Obtaining Accreditation by the Pharmacy Compounding Accreditation Board, Part 2: Developing Essential Standard Operating Procedures	Vol. 11 No. 5	397
Quality-Control Analytical Methods: A Discussion of United States Pharmacopeia Chapter <71> Sterility Tests	Vol. 11 No. 5	400
Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 3: Risk Levels	Vol. 11 No. 5	404
Calculations: Compounding for Veterinary Patients	Vol. 11 No. 5	412
Standard Operating Procedure: Complaint and Mishap Rectification	Vol. 11 No. 5	414
Acetaminophen 500-mg and Diphenhydramine Hydrochloride 25-mg Hot Therapy Packs	Vol. 11 No. 5	416
Acetylcysteine 200-mg/mL Oral Liquid	Vol. 11 No. 5	417
Acetylcysteine 200-mg Packets	Vol. 11 No. 5	418
Betamethasone Valerate 0.1% Topical Gel	Vol. 11 No. 5	419
Dexpanthenol 5% Gel-Cream	Vol. 11 No. 5	420
Diclofenac Sodium 75-mg/mL Injection	Vol. 11 No. 5	421
Ergonovine Maleate 0.2-mg/mL Injection, Veterinary	Vol. 11 No. 5	422
Hydrocortisone 0.5% Ethanolic Gel	Vol. 11 No. 5	423
Neomycin 0.05% Topical Gel	Vol. 11 No. 5	424
Nondetergent Neutral Dry Skin Cream	Vol. 11 No. 5	425
Zinc Content of Commercial Diluents Widely Use in Drug Admixtures Prepared for Intravenous Infusion	Vol. 11 No. 5	426
Isoniazid Release from Suppositories Compounded with Selected Bases	Vol. 11 No. 5	433
PostScription: Thousands of Unapproved New Drugs are on the U.S. Market, Part 2	Vol. 11 No. 5	438
PreScription: Thoughts on Technology and Pharmacy	Vol. 11 No. 6	442
The Internet on Steroids: How Connected is Your Pharmacy?	Vol. 11 No. 6	445
Achievement of USP Chapter <797> Compliance by a 35-Bed Rural Hospital: A Case Study	Vol. 11 No. 6	450
The Internet and Its Websites: Your New Business Partner	Vol. 11 No. 6	472
Proteins Used as Sweeteners	Vol. 11 No. 6	476
Soda Jerk	Vol. 11 No. 6	483
Quality-Control Analytical Methods: In-House Quality Control of Simple Compounds	Vol. 11 No. 6	487
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 4: Considerations in Selection and Use of Disinfectants and Antiseptics	Vol. 11 No. 6	492
Calculations: High-Technology Compounding and Investigational Dispensing	Vol. 11 No. 6	500
Standard Operating Procedure: Vial Crimper--Use, Care, Cleaning, and Maintenance	Vol. 11 No. 6	502
Aloe Vera Gel	Vol. 11 No. 6	504
Breast Care Cream	Vol. 11 No. 6	505
Castor Oil and Trypsin Ointment	Vol. 11 No. 6	506
Chlorhexidine 2% Gel	Vol. 11 No. 6	507
Coal Tar 2% and Allantoin 2.5% Cream	Vol. 11 No. 6	508
Foscarnet 2.5% Topical Cream	Vol. 11 No. 6	509
Interferon alfa-2b Ophthalmic Solution	Vol. 11 No. 6	510
Lidocaine Hydrochloride 1.82% Buffered Injection	Vol. 11 No. 6	511
Miconazole 2% Oral Gel	Vol. 11 No. 6	512
Sodium Phenylbutyrate 200-mg/mL Oral Liquid	Vol. 11 No. 6	513
Topical Pain Relief: Assessment of Patient Satisfaction with a Novel Compound Containing at Least Ketoprofen	Vol. 11 No. 6	514
Palonosetron Hydrochloride Compatibility and Stability with Three Beta-Lactam Antibiotics During Simulated Y-Site Administration	Vol. 11 No. 6	520
PostScription: The History of Pharmacy	Vol. 11 No. 6	526